Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

New single-cell analysis techniques are improving our understanding of stem cells and could help in treating diseases.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Fibroblasts can be turned into melanocytes for potential skin treatments.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Researchers found 15 new genetic links to skin traits in Japanese women.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Steroidogenic isoenzymes may help improve treatments for common hair loss.